New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effect on normal tissue.
New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effect on normal tissue.
复制标题
光动力疗法的新型敏化剂:红紫素的受控合成及其对正常组织的影响。
DOI:
10.1021/jm00124a029
复制
发表时间:
1989
影响因子:
7.3
通讯作者:
Selman,SH
中科院分区:
文献类型:
--
作者:
Morgan,AR;Rampersaud,A;Garbo,GM;Keck,RW;Selman,SH
Purpurins are a class of porphyrin derivative that have been shown to have good in vivo cytotoxicity to iV-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) inducedrat bladder tumors (AY-27) implantedinto Fisher 344 rats. The synthesis of purpurins from etioporphyrin I and coproporphyrin I proceeds in high yieldand with a high degree of regioselectivity. Product formation can be rationalized in terms of relief of steric strain about the periphery of the purpurin macrocycle. The effect of therapeutic light doses using the rat footpad model suggests that, at therapeutic sensitizer doses, normal tissue damage is within acceptable limits, particularly for metalated purpurins.Photodynamic therapy (PDT) has drawn some attention as a new approach to the treatment of selected human neoplasms. The technique uses an exogenously adminis-tered photosensitizer that “localizes” in the neoplasm. In combination with visible (red) light from a laser, a pho-todynamic effect is generated that leads to tumor de-struction. Currently, the most widely used photosensitizer for PDT is hematoporphyrin derivative (HpD) or its pu-tative active component Photofrin II. 1 Although some-what effective in uncontrolled clinical trials, both HpD and Photofrin II are mixtures of various porphyrin species, each of whose contribution to the total biological effectremains unclear. In addition, the absorption maxima of these species are at 630 nm, a region in which light penetration